Gul R, Shawl AI, Kim SH, Kim UH. Cooperative interaction between reactive oxygen species and Ca 2ϩ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 302: H901-H909, 2012. First published December 2, 2011; doi:10.1152/ajpheart.00250.2011.-Reactive oxygen species (ROS) and Ca 2ϩ signals are closely associated with the pathogenesis of cardiac hypertrophy. However, the cause and effect of the two signals in cardiac hypertrophy remain to be clarified. We extend our recent report by investigating a potential interaction between ROS and Ca 2ϩ signals utilizing in vitro and in vivo angiotensin II (ANG II)-induced cardiac hypertrophy models. ANG IIinduced initial Ca 2ϩ transients mediated by inositol trisphosphate (IP3) triggered initial ROS production in adult rat cardiomyocytes. The ROS generated by activation of the NAD(P)H oxidase complex via Rac1 in concert with Ca 2ϩ activates ADP-ribosyl cyclase to generate cyclic ADP-ribose (cADPR). This messenger-mediated Ca 2ϩ signal further augments ROS production, since 2,2=-dihydroxyazobenzene, an ADP-ribosyl cyclase inhibitor, or 8-Br-cADPR, an antagonistic analog of cADPR, abolished further ROS production. Data from short hairpin RNA (shRNA)-mediated knockdown of Akt1 and p47 phox demonstrated that Akt1 is the upstream key molecule responsible for the initiation of Ca 2ϩ signal that activates p47 phox to generate ROS in cardiomyocytes. Nuclear translocation of nuclear factor of activated T-cell in cardiomyocytes was significantly suppressed by treatment with NAD(P)H oxidase inhibitors as well as by shRNA against Akt1 and p47 phox . Our results suggest that in cardiomyocytes Ca 2ϩ and ROS messengers generated by ANG II amplify the initial signals in a cooperative manner, thereby leading to cardiac hypertrophy.
ADP-ribosyl cyclase REACTIVE OXYGEN SPECIES (ROS) and Ca
2ϩ constitute the most important intracellular signaling molecules participating in the regulation and integration of diverse functions (26) . Generation of ROS is regulated by various cytokines and growth factors, including angiotensin (ANG) II, in vascular smooth muscle, cardiomyocytes, afferent arterioles, and mesangial cells (8, 19, 22, 28) . NAD(P)H oxidase, which is similar to the phagocytic enzyme complex, has been identified as a major source of ROS formation in a variety of cell types (8, 19) . Agonist exposure leads to assembly and activation of NAD(P)H oxidase via the translocation of its cytosolic subunits to the membrane and guanine nucleotide exchange of Rac-GDP to form Rac-GTP (1) .
ANG II-induced activation of phospholipase C (PLC) induces hydrolysis of phosphatidylinositol to inositol trisphosphate (IP 3 ) and diacylglycerol (DAG). Both IP 3 -mediated release of Ca 2ϩ from intracellular stores and DAG contribute to the activation of protein kinase C (PKC), which then phosphorylates the p47 phox subunit of NAD(P)H oxidase in serine residues, thereby activating the complex to produce ROS (5) . These observations suggest that Ca 2ϩ acts upstream of ROS and may play an important role in the regulation of NAD(P)H oxidase activation via phosphorylation of p47 phox (2) . On the contrary, however, some recent studies have shown that ANG II-induced ROS production can directly increase the activity of ADP-ribosyl cyclase (ADPR-cyclase) leading to [Ca 2ϩ ] i increase via cyclic ADPribose (cADPR) formation (6, 8, 17, 28, 30) . cADPR is a Ca 2ϩ -mobilizing metabolite generated from nicotinamide adenine dinucleotide (NAD ϩ ) and is known to increase [Ca 2ϩ ] i by releasing Ca 2ϩ from intracellular stores or by Ca 2ϩ influx through plasma membrane Ca 2ϩ channels (11) . Moreover, ROS generation can modulate the activity of Ca 2ϩ release channels (16) , particularly the activity of ryanodine receptors, suggesting that Ca 2ϩ is increased downstream of ROS production (13) . A recent study by Erickson et al. (7) showed that Ca 2ϩ /calmodulin-dependent kinase II is activated by ANG II-induced oxidation. These observations, therefore, suggest that ROS and Ca 2ϩ exert a reciprocal regulation on each other; increased cytoplasmic Ca 2ϩ concentration induces ROS production, whereas increased ROS production leads to intracellular Ca 2ϩ mobilization (9) . However, the mechanisms of linking Ca 2ϩ increase and ROS generation are not clearly understood.
We have recently elucidated the signaling mechanism of ADPR-cyclase activation by ANG II in adult rat cardiomyocytes, and the results indicated that stimulation of type 1 ANG II receptor (AT 1 R) by ANG II leads to sequential activation of several signaling molecules that activate ADPR-cyclase to induce [Ca 2ϩ ] i increase and consequent cardiac hypertrophy (11) . Moreover, we showed that inhibition of ADPR-cyclase by 2,2=-dihydroxyazobenzene (DAB) significantly prevents the development of cardiac hypertrophy in two kidney one clipping (2K1C) renovascular hypertensive rats (12) . In the present study, we demonstrate the interrelationship between ROS and Ca 2ϩ in the ANG II signaling pathway using adult rat cardiomyocytes. Specifically, ANG II-induced Ca 2ϩ and ROS synergistically activate ADPR-cyclase to induce a sustained [Ca 2ϩ ] i increase, eventually leading to cardiac hypertrophy. In addition, the results showed that inhibition of ADPR-cyclase by DAB significantly reduces ROS formation in the hypertrophic myocardium of 2K1C rats.
MATERIALS AND METHODS
Animals. Sprague-Dawley male rats were obtained from Orientbio (Seoungnam, Korea). Animals were housed in a 12-h:12-h light/dark schedule with food and water ad libitum. All studies conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health and were approved by the Institutional Care and Use Committee of Chonbuk National University Medical School.
Ventricular cardiomyocyte isolation and viral transduction. Ventricular cardiomyocytes were isolated from Sprague-Dawley male rats, weighing 200 -220 g, by the method described previously (11) . Cardiomyocytes were transduced with lentiviral particles encoding Akt1 and p47 phox from Santa Cruz Biotechnology (Santa Cruz, CA) at a multiplicity of infection (MOI) of 1-3. Lentiviral transduction procedures were performed essentially according to the manufacturer's protocol. Knockdown efficiency was confirmed by immunoblotting (Fig. 4, A  and B) .
Surgical preparation. Renovascular hypertension was produced by 2K1C as described previously (12) . Sprague-Dawley male rats (7-9 wk old and weighing 200 -220 g) were anesthetized with ketamine (100 mg/kg ip) and rumpen (5 mg/kg ip). To investigate the effect of our recently discovered ADPR-cyclase inhibitor DAB (Sigma-Aldrich, St. Louis, MO) (12) on ROS production in 2K1C rats, DAB was injected intraperitoneally with a dose of 1.5 l/g body wt (428 g/200 g/day) at day 7 after the surgery for 7 wk (12) . Sham group and control 2K1C received vehicle treatment.
Measurement of intracellular ROS. The redox-sensitive dye 2,7-dichlorodihydrofluorescein diacetate (DCFDA; Molecular Probe, Eugene, OR) was used to assess the presence of ROS in cardiomyocytes. Cardiomyocytes attached to laminin-coated plates were loaded with the redox-sensitive dye DCFDA (4 M) for 20 min at 37°C. Cells were then rinsed twice with stabilizing buffer containing (in mM): 20 HEPES, 137 NaCl, 4.9 KCl, 1.2 MgSO4, 15 glucose, 4.2 NaHCO3, and 1 CaCl 2 (pH 7.4), and they were preincubated with various drugs at 37°C for 30 min before treatment with ANG II (150 nM). DCFDA fluorescence was detected at excitation and emission wavelengths of 488 and 520 nm, respectively, using a fluorescence photometer, Spectra Max Gemini (Molecular Devices, Sunnyvale, CA). For confocal microscopic images, chambered coverslips were used as described before (3). Cardiomyocytes were visualized using a confocal scanning microscope at 488/520 nm wavelengths for visualization of green fluorescence. Moreover, to assess ROS production in tissue sections, fresh frozen left ventricular myocardium (10 m slices) was loaded with 2 M dihydroethidium (DHE; Molecular Probe) for 1 h at 37°C and fluorescence was determined (21) .
Measurements of superoxide production. NADPH oxidase-dependent superoxide production in cardiomyocytes and membrane fractions of the left ventricle (LV) was measured by lucigenin chemiluminescence as described previously (21) . Briefly, proteins were diluted in HEPES buffer containing (in mM): 140 NaCl, 5 KCl, 0.8 MgCl2, 1 CaCl2, 1 Na2HPO4, 25 HEPES, and 1% glucose (pH 7.2). The reaction was started by adding NAD(P)H (100 M) and darkadapted 5 M lucigenin to each well for a final volume of 250 l as described. Lucigenin chemiluminescence was recorded for 5 min and was expressed as units per minute per milligram of weight (of protein).
Immunoblotting. Immunoblotting was performed as described previously (11) . Cytosolic and nuclear fractions were prepared with a Pierce (catalog no. 78833) nuclear and cytoplasmic extraction kit according to the manufacturer's directions (Pierce, Rockford, IL). Proteins were resolved on 10% or 12% SDS-PAGE gel and transferred to polyvinylidene difluoride (GE Healthcare, Little Chalfont, Buckinghamshire, UK) membranes. Nonspecific sites were blocked with 5% nonfat milk in Tris-buffered saline with Tween 20 (TBST) 20 mM Tris·HCl (pH 7.5), 150 mM NaCl, and 0.1% Tween 20 for 1 h. Blots were incubated with primary antibodies p47 phox , gp91 phox (1:1,000 dilution; Santa Cruz Biotechnology), NFAT3 (1:2,500 dilution; Santa Cruz Biotechnology), or ␤-actin (1:1,500 dilution; Cell Signaling) overnight at 4°C. The blots were rinsed three times with TBST and incubated with horseradish peroxidase-conjugated secondary antibodies (1:5,000 dilutions; Santa Cruz Biotechnology) for 1 h at room temperature. Immunoreactive bands were visualized by enhanced chemiluminescence reaction (GE healthcare, Buckinghamshire, UK). Protein concentration was determined using a Bio-Rad protein assay kit, using known concentrations of BSA as the standard. Measurement of cADPR and NAD concentration. Cyclic enzymatic assay was used to measure cADPR levels as described previously (11, 20) . NAD levels were measured as described previously (10) . Fluorescence was measured at excitation/emission wavelength of 544/590 nm using a fluorescence plate reader (Spectra-Max GEMINI; Molecular Devices).
Measurement 
, where Kd is 450 nM for Fluo 3 and F is the observed fluorescence levels. Each tracing was calibrated for the maximal intensity (Fmax) by addition of ionomycin (8 M) and for the minimal intensity (Fmin) by addition of EGTA 50 mM at the end of each measurement.
Measurements of Rac1 activation. Activated Rac1 was determined by the p21-binding domain of p21-activated protein kinase 1 pulldown assay (Rac1 Activation Assay Kit; Upstate Biotechnology) according to the manufacturer's protocol.
[ 3 H]leucine incorporation. Cardiomyocytes in 12 well plates were exposed to ANG II (150 nmol/l) in the presence or absence of blockers for 24 h. They were then incubated in the same medium with 1.0 Ci/ml [ 3 H]leucine for 12 h, and then processed for determination of incorporated radioactivity after precipitation with 10% TCA as described previously (11) .
Statistical analysis. Values are means Ϯ SE of three separate experiments. Statistical comparisons were performed using one-way ANOVA followed by the Scheffe's test. Statistical significance of difference between groups was determined using the Student's t-test. A value of P Ͻ 0.05 was considered to be significant.
RESULTS

ANG II increases ROS production in rat cardiomyocytes and is mediated by NAD(P)H oxidase.
Treatment of cardiomyocytes with ANG II increased DCFDA fluorescence in a timedependent manner ( Fig. 1, A and B) , which is blunted by AT 1 receptor (AT 1 R) inhibitor, losartan (Fig. 1, C and D) . Pretreatment of cardiomyocytes with NAD(P)H oxidase inhibitors like diphenylene iodonium (DPI), a flavoprotein-containing enzyme, and apocynin (Apo) completely abolished the ANG II-induced increase of DCFDA fluorescence (Fig. 1, C and D) . The involvement of NAD(P)H oxidase in ROS production was further confirmed by a more specific NAD(P)H oxidase inhibitor, gp91ds-tat (29) . Pretreatment of cardiomyocytes with gp91ds-tat significantly attenuated the ANG II-induced increase in ROS production, whereas scrambled gp91ds-tat had no effect (Fig. 1, E and F) . Moreover, we also checked the effects of mitochondrial complex I inhibitor rotenone and nitric oxide synthase (NOS) inhibitor N G -nitro-L-arginine methyl ester (L-NAME) on ANG II-induced ROS production ( Fig. 1 , E and F). Both rotenone and L-NAME had no significant inhibitory effect on ANG II-induced ROS production. Together, these results suggest that ANG II-induced AT 1 R stimulation induces ROS generation in cardiomyocytes through a NA-D(P)H oxidase-derived superoxide pathway. (11) . To explore the mechanism of ROS generation we measured the effect of gp91ds-tat and scrambled gp91ds-tat on ANG II-mediated [Ca 2ϩ ] i signal . Pretreatment with scrambled gp91ds-tat had no effect on ANG II-induced Ca 2ϩ rise, whereas as gp91ds-tat significantly decreased the sustained Ca 2ϩ increase but not the initial Ca 2ϩ peak (Fig. 2, B and C) . Similarly, pretreatment of cardiomyocytes with Apo and DPI decreased only sustained Ca 2ϩ rise but not the initial Ca 2ϩ rise. Activation of PKC is required for phosphorylation of p47 subunit, an important step for the activation of NAD(P)H oxidase (5) . To investigate whether PKC plays a role in ANG II signaling we tested the effect of calphostin C, a broad spectrum inhibitor of PKC on ANG II-induced Ca 2ϩ increase. Pretreatment with calphostin C had an effect similar to that of DPI and Apo on both initial as well as sustained Ca 2ϩ signals (Fig. 2D) . We have shown previously an increase in Akt phosphorylation by ANG II treatment (11) . To further determine the role of Akt in the ANG II signaling we checked the effect of API-59CJ-OH (API), an Akt1 specific inhibitor (25), on ANG II-mediated [Ca 2ϩ ] i . As expected, pretreatment with API completely blocked both initial as well as sustained Ca 2ϩ increase to the basal level, again demonstrating a role of Akt1 in ANG II-signaling (Fig.  2E) . Taken together these data indicate that NAD(P)H-oxidase activation was required for ANG II-induced [Ca 2ϩ ] i signaling via Akt pathway.
NAD(P)H oxidase is required for ANG II-mediated [
To further investigate the role of NAD(P)H-oxidase in ANG II Ca 2ϩ signaling, we checked the effect of DPI and API on cADPR production, a product of ADPR-cyclase required for sustained [Ca 2ϩ ] i (11) . ANG II treatment increased cADPR generation in cardiomyocytes, which was significantly abrogated by pretreatment with these inhibitors (Fig. 2G) . We also measured levels of NAD, in the presence of DPI and Apo to confirm a correlation between product and substrate levels. ANG II treatment decreased NAD levels in cardiomyocytes compared with untreated control, which was significantly abolished by pretreatment with DPI and Apo (Fig. 2H) . These data suggest that ANG II-induced ROS generation is required for activation of ADPR-cyclase and sustained [Ca 2ϩ ] i rise to some extent, and the inhibition of ROS generation by blocking the action of NAD(P)H oxidase decrease both ADPR-cyclase activity and subsequent [Ca 2ϩ ] i increase. (11), DAB, an ADPR-cyclase inhibitor (12) and an intracellular Ca 2ϩ chelator, BAPTA-AM (Fig. 3, A  and B) . Pretreatment of cardiomyocytes with 8-Br-cADPR or DAB significantly reduced ANG II-elicited ROS generation, whereas xestospongin C, calphostin C, and BAPTA-AM completely prevented this response. Taken together, these results suggest that Ca 2ϩ signaling by IP 3 and ADPR-cyclase activation is required for ANG II-induced sustained ROS generation and that IP 3 and PKC are the upstream mediators for ROS production.
Treatment with ANG II significantly increased the expression levels of cytoplasmic factor p47 phox and cell membrane protein gp91
phox, in a time-dependent manner (Fig. 3C) . We next studied the effect of xestospongin C, calphostin C, 8-BrcADPR, and DAB on p47 phox and gp91 phox protein expression, to probe possible mechanisms where ANG II-induced Ca 2ϩ increase regulates ROS production (Fig. 3D) . The results showed a significant decrease in the protein levels of p47 phox and gp91
phox by all these inhibitors. However, the inhibitory effects of xestospongin C and calphostin C were higher than those of DAB and 8-Br-cADPR. We then assessed ANG II-induced Rac1 activation by a Rac1 pull down assay. Treatment of cardiomyocytes with ANG II significantly increased GTP-Rac1 in a time-dependent manner compared with untreated control (Fig. 3E) . Consistently, pretreatment of cardiomyocytes with xestospongin C, losartan, caphostin C, and API completely inhibited ANG II-stimulated Rac1 activation, whereas 8-Br-cADPR significantly, but not completely, inhibited the Rac1 activation (Fig. 3F) . Taken together these data are consistent with the above results from ROS generation concluding that ANG II-induced initial [Ca 2ϩ ] i increase via IP 3 R is needed to elicit initial ROS generation, which in turn activated ADPR-cyclase/cADPR to further enhance the initial Ca 2ϩ signal and ROS generation.
Downregulation of Akt1 and p47 phox gene expression abolished ANG II-induced signaling events.
To substantiate the upstream and downstream signaling pathway, we checked the role of Akt1 and p47 phox by downregulating the gene expression of these molecules by using short hairpin RNA (shRNA) knockdown technology. Using lentiviral transduction particles containing shRNAs for target genes, we were able to downregulate Ϸ80% of Akt1 and Ϸ70% of p47 phox gene expression in cardiomyocytes, as detected by immunoblot analyses (Fig. 4, A  and B) . Downregulation of Akt1 and p47 phox significantly decreased ANG II-induced ROS generation to nontreated control levels (Fig. 4, C and D) . Moreover, shRNA-mediated knock- down of Akt1 significantly reduced ANG II-induced cADPR formation to control levels (Fig. 4E) , whereas shRNA-mediated knockdown of p47 phox partially inhibited ANG II-induced cADPR formation (Fig. 4E) . To corroborate these effects, we directly checked the effect of downregulation of Akt1 and p47 phox on ANG II-induced [Ca 2ϩ ] i increases. Knockdown of Akt1 completely blocked ANG II-induced Ca 2ϩ increase (Fig.  4H) , whereas knockdown of p47 phox partially inhibited only the sustained Ca 2ϩ increase by ANG II in cardiomyocytes (Fig.  4I) . These data support a possibility of Akt1 being activated upstream of p47 phox and that both Akt1 and p47 phox are important signaling players in ANG II-signaling in cardiomyocytes.
ANG II-induced hypertrophic responses in isolated cardiomyocytes require NAD(P)H oxidase activation.
Our recent work has highlighted data suggesting ANG II induce cardiac hypertrophy by increasing NFAT3 nuclear translocation (12) . To examine whether ANG II-induced stimulation of NAD(P)H oxidase activates NFAT3, we measured NFAT3 protein expression in nuclear and cytosolic fractions of cardiomyocytes treated with DPI and Apo before ANG II treatment. Consistent with our previous data, treatment of cardiomyocytes with ANG II increased levels of NFAT3 in the nuclear fraction compared with that in the control, whereas pretreatment with Apo and DPI significantly reduced ANG II-induced NFAT3 nuclear translocation (Fig. 5A) . These results indicate that ANG IIinduced NAD(P)H oxidase activation led to NFAT3 translocation. Next, we examined the effect of DPI and Apo on ANG II-induced hypertrophy by measuring [ 3 H]leucine incorporation in cardiomyocytes (Fig. 5B) . As expected, ANG II induced an increase of [ 3 H]leucine incorporation, whereas it was significantly ameliorated after treatment with Apo and DPI. These results indicate that ANG II-induced NAD(P)H oxidase activation mediates hypertrophy in isolated cardiomyocytes. On the same line, we determined that downregulation of Akt1 and p47 phox significantly reduced ANG II-induced NFAT3 nuclear translocation in cardiomyocytes (Fig. 5, C and D) , suggesting that both Akt1 and p47 phox play a potential role in ANG II-induced cardiac hypertrophy in vitro.
Inhibition of ADPR-cyclase activation by DAB reduces NAD(P)H oxidase-dependent superoxide generation in 2K1C
rat model. Our previous echocardiographic data have shown an increase in cardiac hypertrophy as depicted by an increase in LV mass, posterior wall thickness, LV end-diasystolic diameter, and decrease in fractional shortening in 2K1C rats compared with sham (12) . Treatment with DAB not only amelio- rated cardiac hypertrophy but also improved cardiac function indicating that ADPR-cyclase plays an important role in cardiac hypertrophy (12) . To ascertain in vivo data on whether ADPR-cyclase plays a role in ANG II-induced ROS generation as well, we studied ROS generation by NAD(P)H oxidase and gp91 phox protein levels and membrane translocation of p47 phox in 2K1C rats treated with DAB. Interestingly, 2K1C rats showed an increase of ROS generation compared with shamoperated rats, which was significantly reduced when treated with DAB (Fig. 6, A and B) . Furthermore, 2K1C rats showed significantly higher NAD(P)H oxidase derived superoxide production, gp91 phox protein levels, and increased p47 phox expression in membrane fractions than those of control rats, which were reduced by DAB treatment (Fig. 6, C and D) . However, no significant differences in ROS generation by NAD(P)H oxidase, or gp91 phox protein levels and p47 phox protein expres- sion in membrane fractions, were observed in sham-operated rats or sham-operated rats treated with DAB. These data together indicate that ADPR-cyclase activation induces ROS generation, which in turn induces cardiac hypertrophy in 2K1C rats.
DISCUSSION
In the present study, we attempted to elucidate the signaling mechanism involved in ANG II-induced ROS generation in adult rat cardiomyocytes and the role of ADPR-cyclase in ROS generation. The results for the first time reveals that ANG II-induced activation of ADPR-cyclase is required for sustained ROS generation and that the latter in turn activates ADPR-cyclase, thus forming a cooperative loop (Fig. 7) . The current findings indicate that ANG II-induced ROS generation in cardiomyocytes may play an important role in hypertrophy that seems to be an outcome of cADPR-mediated long-lasting Ca 2ϩ increase and ROS production. Previous studies have demonstrated that ROS regulates ADPR-cyclase activity in a variety of cells (6, 8, 30 ). Therefore, increase of cADPR production by ROS could critically be involved in the regulation of intracellular Ca 2ϩ mobilization during oxidative stress. In agreement with such a view, our present study demonstrated that NAD(P)H oxidase inhibition by DPI and Apo significantly decreased ANG II-induced cADPR formation and sustained Ca 2ϩ increase, compared with ANG II-treated control, indicating that ROS generation is required for ADPR-cyclase activation. On the contrary, inhibition of ADPR-cyclase activity by DAB and blocking of cADPR action by 8-Br-cADPR reduced ANG II-induced ROS generation by NAD(P)H oxidase, indicating that ADPR-cyclase activation by ANG II is required for full enzymatic activity of NAD(P)H oxidase. Based on these findings we propose that both ROS and Ca 2ϩ synergistically activate ADPR-cyclase, to induce a sustained [Ca 2ϩ ] i increase that in turn activates NAD(P)H oxidase and leads to long-lasting ROS generation.
ROS generation has been shown to induce sustained elevation of [Ca 2ϩ ] i , which is attributed to either mobilization from intracellular stores or Ca 2ϩ influx across plasma membrane or both (13, 16, 24, 31) . We have reported previously that ANG II-stimulated activation of upstream signaling molecules such as Src, PI3K/Akt, and PLC/IP 3 induces an initial Ca 2ϩ increase, which in turn triggers ADPR-cyclase/cADPR activation, resulting in sustained Ca 2ϩ increase via Ca 2ϩ influx from the extracellular space (11, 15) . Here, we provide evidence that the initial Ca 2ϩ increase stimulates NAD(P)H oxidase, by which generated ROS activates ADPR-cyclase. Our data showed that the inhibitory effects of calphostin C and xestospongin C on ANG II-induced ROS production, protein expression levels of key enzymatic components of NAD(P)H oxidase, and Rac1 activation were higher, compared with those by DAB and 8-Br-cADPR. Thus we established that ANG II-induced initial [Ca 2ϩ ] i increase via IP 3 R and DAG contributes to the activation of PKC, which then phosphorylates p47 phox forming an activated NAD(P)H oxidase complex to elicit initial ROS generation. Both the resulting ROS as well as Ca 2ϩ in turn activates ADPR-cyclase/cADPR to further enhance the initial Ca 2ϩ signal via extracellular Ca 2ϩ influx and ROS generation. These results are further supported with knockdown of Akt1 and p47 phox by using lentiviral particles containing shRNA for these target genes. The data obtained support a possibility of Akt1 being the upstream key molecule responsible for the initiation of Ca 2ϩ signaling and ROS generation, whereas p47 phox activation occurs downstream of the initial Ca 2ϩ signal induced by ANG II via the Akt and IP 3 pathway.
To validate our in vitro observations that ANG II-induced ADPR-cyclase activation is required for ROS generation, we examined the effects of DAB on ROS generation in 2K1C rat model of hypertension. In untreated 2K1C rats, ROS generation was increased markedly as depicted by DHE fluorescence; however, DAB treatment significantly reduced ROS generation. Moreover, DAB treatment significantly decreased superoxide generation by NAD(P)H oxidase in 2K1C rats. This observation further confirmed the above observations that activation of ADPR-cyclase is essential for long-lasting ROS generation and also suggests that the development of cardiac hypertrophy in 2K1C rats is from the cooperative effect of Ca 2ϩ and ROS. In agreement with this view, several recent studies have demonstrated that ROS generation (21) as well as imbalanced homeostasis of calcium (11, 12, 15 ) plays a critical role in the pathogenesis of ANG II. Thus inhibition of either Ca 2ϩ increase or ROS generation is expected to provide protection against cardiac hypertrophy. Therefore, it is possible that the protection from ANG II-induced cardiac hypertrophy by DAB could be due to the beneficial reduction of [Ca 2ϩ ] i and oxidative stress.
The notion that NAD(P)H oxidase-mediated ROS generation is involved in ANG II-induced cardiac hypertrophy (4, 14, 18, 23) was proved by demonstrating that NAD(P)H oxidase inhibitors suppressed both ANG II-mediated nuclear NFAT3 nuclear expression as well as protein synthesis. Moreover, infection of cardiomyocytes with lentiviral particles against Akt1 and p47 phox significantly reduced ANG II-induced NFAT3 nuclear translocation compared with that of cells infected with control shRNA. These observations suggest that ROS generation by NAD(P)H oxidase plays an important role in ANG II-induced hypertrophic responses (19, 21) .
In summary, the present study in adult rat cardiomyocytes for the first time reveals a crosstalk between [Ca 2ϩ ] i signaling and ROS generation in response to ANG II. The results show that ANG II-signaling mechanism uses ADPR-cyclase as a link between [Ca 2ϩ ] i and oxidants to induce sustained [Ca 2ϩ ] i increase that finally leads to hypertrophy in isolated cardiomyocytes.
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